Skip to content
Screener

Neogen NEOG Q4 2026 Annual earnings

Reported July 30, 2026 · Before market open

Revenue$225.3MBeat by $13.0M
EPS$0.09Beat by $0.03
Revenue estimate$212.4M
EPS estimate$0.06
“We ended fiscal year 2026 with significant momentum and have a number of initiatives underway to further enhance our commercial efforts and the way we approach customers and our core markets. Fiscal year 2027 will be a year of disciplined execution and investment in core areas as we look to drive high-impact innovation and operational efficiency through additive technology and improved process. Ultimately, our goal is to exit FY27 positioned for enhanced future growth and profitability”
Mike Nassif

Next report

Date not yet announced

Financials

Q4 2026

Income statement

See full
Revenue$225.3M-0.1%
Gross profit$107.8M+16.0%
Net income-$11.3M+98.2%
EPS (diluted)-$0.06+97.9%

Balance sheet

See full
Cash & equivalents$185.5M+43.8%
Total debt$812.7M-11.2%
Total equity$2.1B+1.0%
Total assets$3.3B-2.8%

Cash flow

See full
Operating cash flow$30.2M+84.1%
CapEx$4.0M-75.2%
Free cash flow$7.8M—

Valuation & ratios

Valuation

as of 05/31/26
See full
Market cap$1.95B+46.3%
Enterprise value$2.58B+21.6%
P/S2.2×+0.8×

Profitability

See full
Gross margin46.9%-0.2pp
Net margin-0.9%-0.5pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.4×-0.1×
Current ratio3.8×+0.5×

Segments

By product

See full
Indicator Testing And Culture Media$86.8M—
Bacterial And General Sanitation$46.7M+9.9%
Genomics Services$23.8M+4.4%
Natural Toxins And Allergens$19.2M+3.8%
Animal Care And Other$7.0M-12.5%

By segment

See full
Food Safety$166.8M+3.1%
Animal Safety$58.5M-8.2%

FAQ

When did Neogen report Q4 2026 earnings?
Neogen (NEOG) reported Q4 2026 earnings on July 30, 2026 before market open.
What were Neogen's Q4 2026 revenue and EPS?
Neogen reported revenue of $225.3M and eps of $0.09 for Q4 2026.
Did Neogen beat estimates in Q4 2026?
Revenue beat the consensus estimate of $212.4M by $13.0M. EPS beat the consensus estimate of $0.06 by $0.03.
How did Neogen's Q4 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.1% from $225.5M a year earlier and eps grew 80.0% from $0.05.
Where can I find Neogen's Q4 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-324860) and the 10-K periodic report (0001193125-26-326092) directly on SEC EDGAR. The filing index links above go to sec.gov.